购物车
- 全部删除
- 您的购物车当前为空
GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain.
GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 22,700 | 10-14周 | |
50 mg | ¥ 30,300 | 10-14周 | |
100 mg | ¥ 39,500 | 10-14周 |
产品描述 | GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain. |
靶点活性 | Nav1.6 (human):29 nM (ki), Nav1.2 (human):12 nM (ki), Nav1.7 (human): kd:0.38 nM , Nav1.7 (human):ki:0.79 nM |
体外活性 | Site-directed mutagenesis is critical for the isoform selectivity profile of GNE-616. |
体内活性 | GNE-616 shows robust activity in a Nav1.7-dependent inherited erythromelalgia (IEM) PK/PD model. |
分子量 | 537.53 |
分子式 | C24H23F4N5O3S |
CAS No. | 2349371-81-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.